Journal of Clinical Immunology

, Volume 28, Issue 4, pp 285–290 | Cite as

Antibodies to Mitotic Spindle Apparatus: Clinical Significance of NuMA and HsEg5 Autoantibodies

Article

Abstract

Introduction

The clinical associations of NuMA and HsEg5 antibodies, the main anti-mitotic spindle apparatus autoantibodies, remain unclear due to their extremely low prevalence.

Patients and Methods

We have analysed the clinical data of 40 anti-NuMA- (0.87‰) and 7 anti-HsEg5- (0.15‰) positive patients detected during routine immunofluorescence examination of 45,804 sera. NuMA reactivity was further confirmed by immunoblotting.

Results

Antibodies to HsEg5 did not associate with any specific pathology. NuMA positivity associated with a diagnosis of connective tissue disease (CTD) in 18 patients (45%), primary Sjögren or sicca syndrome and undifferentiated connective tissue disease being the most represented. Seven patients (17.5%) were diagnosed with different organ-specific autoimmune diseases, whereas in the other 15 patients (37.5%), no autoimmune pathology could be documented.

Conclusions

Therefore, although both anti-mitotic spindle apparatus antibodies are not associated to a defined autoimmune pathology, the presence of NuMA antibodies, mainly at high titers, may be an indication for a more extensive screening of CTD.

Keywords

Mitotic spindle apparatus autoantibodies NuMA protein HsEg5 protein connective tissue diseases 

Notes

Acknowledgments

This work was supported in part by the Asociación Lúpicos de Asturias (Association of lupus patients of Asturias, Spain).

References

  1. 1.
    Rattner JB, Mack GJ, Fritzler MJ. Autoantibodies to components of the mitotic apparatus. Mol Biol Rep. 1998;25:143–55.PubMedCrossRefGoogle Scholar
  2. 2.
    McCarty GA, Valencia DW, Fritzler MJ, Barada FA. A unique antinuclear antibody staining only the mitotic spindle apparatus (letter). New Engl J Med. 1981;305:703.PubMedCrossRefGoogle Scholar
  3. 3.
    Andrade LE, Chan EK, Peebles CL, Tan EM. Two major autoantigen–antibody systems of the mitotic spindle apparatus. Arthritis Rheum. 1996;39:1643–53.PubMedCrossRefGoogle Scholar
  4. 4.
    Whitehead CM, Winkfein RJ, Fritzler MJ, Rattner JB. The spindle kinesin-like protein HsEg5 is an autoantigen in systemic lupus erythematosus. Arthritis Rheum. 1996;39:1635–42.PubMedCrossRefGoogle Scholar
  5. 5.
    Lydersen BK, Pettijohn DE. Human-specific nuclear protein that associates with the polar region of the mitotic apparatus: distribution in a human/hamster hybrid cell. Cell 1980;22:489–99.PubMedCrossRefGoogle Scholar
  6. 6.
    Tousson A, Zeng C, Brinkley BR, Valdivia MM. Centrophilin: A novel mitotic spindle protein involved in microtubule nucleation. J Cell Biol. 1991;112:427–40.PubMedCrossRefGoogle Scholar
  7. 7.
    Kallajoki M, Weber K, Osborn M. A 210 kDa nuclear matrix protein is a functional part of the mitotic spindle; a microinjection study using SPN monoclonal antibodies. EMBO J. 1991;10:3351–62.PubMedGoogle Scholar
  8. 8.
    Maekawa T, Leslie R, Kuriyama R. Identification of a minus end-specific microtubule-associated protein located at the mitotic poles in cultured mammalian cells. Eur J Cell Biol. 1991;54:255–67.PubMedGoogle Scholar
  9. 9.
    Price CM, McCarty GA, Pettijohn DE. NuMA protein is a human autoantigen. Arthritis Rheum. 1984;27:774–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Auer-Grumbach P, Achleitner B. Epidemiology and clinical associations of NuMA (nuclear mitotic apparatus protein) autoantibodies. J Rheumatol. 1994;21:1779–81.PubMedGoogle Scholar
  11. 11.
    Grypiotis P, Ruffatti A, Tonello M, Winzler C, Radu C, Zampieri S, et al. Significato clinico dei quadri fluoroscopici specifici per il fuso mitotico in pazienti affetti da malattie reumatiche. Reumatismo 2002;54:232–7.PubMedGoogle Scholar
  12. 12.
    Bonaci-Nikolic B, Andrejevic S, Bukilica M, Urosevic I, Nikolic M. Autoantibodies to mitotic apparatus: Association with other autoantibodies and their clinical significance. J Clin Immunol. 2006;26:438–46.PubMedCrossRefGoogle Scholar
  13. 13.
    Claus R, Lenschow U, Külz T, Kotitschke A, Meiske D, Thiesen HJ, et al. Congenital heart block associated with a maternal anti-HsEg5-like autoantibody. Rheumatology 2005;44:693–5.CrossRefGoogle Scholar
  14. 14.
    Claus R, Hickstein H, Külz T, Lenschow U, Meiske D, Kotitscke A, et al. Identification and management of fetuses at risk for, or affected by, congenital heart block associated with autoantibodies to SSA (Ro), SSB (La), or an HsEg5-like autoantigen. Rheumatol Int. 2006;26:886–95.PubMedCrossRefGoogle Scholar
  15. 15.
    Lind K, Hoier-Madsen M, Wiik A. Autoantibodies to the mitotic spindle apparatus in Mycoplasma pneumoniae disease. Infect Immun. 1988;56:714–5.PubMedGoogle Scholar
  16. 16.
    Hansen BU, Eriksson S, Lindgren S. High prevalence of autoimmune liver disease in patients with multiple nuclear dot, anti-centromere, and mitotic spindle antibodies. Scand J Gastroenterol. 1991;26:707–13.PubMedCrossRefGoogle Scholar
  17. 17.
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–24.PubMedCrossRefGoogle Scholar
  18. 18.
    Lonzetti SL, Joyal F, Raynauld JP, Roussin A, Goulet JR, Rich E, et al. Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum. 2001;44:735–6.PubMedCrossRefGoogle Scholar
  19. 19.
    Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.PubMedCrossRefGoogle Scholar
  20. 20.
    Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexandre EL, Carsons SE, et al. Classification criteria for Sjögren´s syndrome: a revised version of the European criteria proposed by the American–European Consensus Group. Ann Rheum Dis. 2002;61:554–8.PubMedCrossRefGoogle Scholar
  21. 21.
    Fries JF, Hunder GG, Bloch DA, Michel BA, Arend WP, Calabrese LH, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary. Arthritis Rheum. 1990;33:1135–6.PubMedCrossRefGoogle Scholar
  22. 22.
    Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994;37:187–92.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Lourdes Mozo
    • 1
  • Carmen Gutiérrez
    • 1
    • 2
  • Jesús Gómez
    • 1
  1. 1.Department of ImmunologyHospital Universitario Central de AsturiasOviedoSpain
  2. 2.Department of Functional Biology, Immunology AreaUniversity of OviedoOviedoSpain

Personalised recommendations